We experienced a case of primary percutaneous coronary intervention for ST‐elevation
myocardial infarction (STEMI) with coronavirus disease 2019 (COVID‐19) using appropriate …

Choice of initial revascularization strategy is unclear in Covid-19 patients with acute ST-
elevation myocardial infarction (STEMI). We present clinical, angiographic profile, and …

Background: In the Coronavirus Disease 2019 (COVID-19) pandemic, the appropriate
reperfusion strategy in patients with ST-segment elevation myocardial infarction (STEMI) is …

Abstract Background Coronavirus disease-2019 (COVID-19) is an infectious disease
appeared in China in December 2019 and, since then, has spread worldwide at a rapid …

Background Coronavirus disease-2019 (COVID-19) is thought to predispose patients to
wide variety of thrombotic disease, including Acute Coronary Syndromes (ACS). While such …

Background: COVID-19 can cause a wide range of thrombotic diseases, including acute
coronary syndromes (ACS). While these thrombotic diseases occur during acute infection …

The pathophysiology of ST-elevation myocardial infarction (STEMI) is not well understood in
Coronavirus disease 2019 (COVID-19). We present similar angiographic findings in two …

Abstract The coronavirus disease‐2019 (COVID‐19) is a viral illness with heterogenous
clinical manifestations, ranging from mild symptoms to severe acute respiratory distress …

A life-threatening cardiovascular-emergency called ST elevation myocardial infarction
(STEMI) necessitates immediate intervention for reperfusion. COVID-19 has a negative …

DISCUSSION: ST-segment elevation myocardial infarction (STEMI) is commonly
encountered in patients with COVID-19 infection. About 40% of COVID-19 patients with …